Body

Drug blocks two of world's deadliest emerging viruses

NEW YORK (March 5, 2009) -- Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology. Due to the study's significance, a manuscript was published yesterdayonline, in advance of the print issue, and will be highlighted as aneditor's "spotlight" in the first May issue.

Support for adjunctive vitamin C treatment in cancer

New Rochelle, NY, March 5, 2009—Serious flaws in a recent study, which concluded that high doses of vitamin C reduce the effectiveness of chemotherapeutic drugs in the treatment of cancer, are revealed in the current issue of Alternative and Complementary Therapies, a journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). This report is available free online at www.liebertpub.com/act

Exposure to family violence compromises physical and mental health of older women

New Rochelle, NY, March 5, 2009—Older African American women exposed to high levels of family violence during their lifetimes are at significantly greater risk of poor health status, according to a report in the current issue of Journal of Women's Health, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). This report is available free online at www.liebertpub.com/jwh

Discovery of a new retinal gene involved in childhood blindness

Montreal March 2nd, 2009 – The team of Dr. Robert Koenekoop which includes Dr. Irma Lopez from the Research Institute of the MUHC at the Montreal Children's Hospital played a crucial role in the international collaboration that led to the discovery of a new gene that causes Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP), two devastating forms of childhood blindness.

Virus-free embryonic-like stem cells made from skin of Parkinson's disease patients

Researchers reporting in the March 6th issue of the journal Cell, a Cell Press publication, have developed a new way to produce human embryonic-like stem cells that are free of the viruses used to insert the key ingredients. They showed they could make those embryonic-like cells by reprogramming cells taken from people with unexplained (or idiopathic) Parkinson's disease.

The making of an intestinal stem cell

Researchers have found the factor that makes the difference between a stem cell in the intestine and any other cell. The discovery reported in the March 6th issue of the journal Cell, a Cell Press publication, is an essential step toward understanding the biology of the stem cells, which are responsible for replenishing all other cells in the most rapidly self-renewing tissue in mammals. It may also have implications for colon cancer, according to the researchers.

McMaster study sheds light on how stem cells develop into blood cells

Hamilton, ON (March 3, 2009) - How messages sent within stem cells through a specific communication pathway can trigger the cells to specialize and become blood cells in humans, has been discovered by scientists of the McMaster Stem Cell and Cancer Research Institute.

New research sheds light on how stem cells turn into blood cells

March 5, 2009 Hamilton – Researchers funded by the Canadian Cancer Society have discovered how certain messages that are carried within stem cells can trigger those cells to become blood cells. The findings are published online today in Cell Stem Cell.

CU-Boulder research team identifies stem cells that repair injured muscles

A University of Colorado at Boulder research team has identified a type of skeletal muscle stem cell that contributes to the repair of damaged muscles in mice, which could have important implications in the treatment of injured, diseased or aging muscle tissue in humans, including the ravages of muscular dystrophy.

Education may improve hospital prescription rate of emergency contraception to teens

PHILADELPHIA, March 5, 2009 – Many doctors don't offer emergency contraception pills to adolescents who may benefit from them during emergency department visits because of misinformation about how the medicine works, according to a study by The Children's Hospital of Philadelphia.

Clinical trial finds microbicide promising as HIV prevention method for women

March 5, 2009 -- A clinical trial involving more than 3,000 women in the U.S. and southern Africa demonstrates for the first time the promise of a vaginal microbicide gel for preventing HIV infection in women. According to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI), one 0.5 % dose of a microbicide designed to prevent HIV from attaching to cells in the genital tract, was 30% effective.

Drug blocks 2 of world's deadliest emerging viruses

NEW YORK (March 5, 2009) -- Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology. Due to the study's significance, it was published yesterday, online, in advance of the first April print issue.

New deep-sea coral discovered on NOAA-supported mission

Scientists identified seven new species of bamboo coral discovered on a NOAA-funded mission in the deep waters of the Papahānaumokuākea Marine National Monument. Six of these species may represent entirely new genera, a remarkable feat given the broad classification a genus represents. A genus is a major category in the classification of organisms, ranking above a species and below a family. Scientists expect to identify more new species as analysis of samples continues.

7 steps to successful child and adolescent weight loss

New Rochelle, NY, March 4, 2009—Overweight children and adolescents, with the active involvement of their parents and families, can successfully lose weight by following the Seven Steps to Success described in the current issue of Obesity Management, a journal published by Mary Ann Liebert, Inc. The article is available free online at www.liebertpub.com/obe

GEN reports biomanufacturers target a fully disposable process stream

New Rochelle, NY, March 4, 2009--The disposable bioprocessing market has moved far beyond plastic bags for buffer preparation toward a range of products for cell culture and upstream and downstream operations, reports Genetic Engineering & Biotechnology News (GEN). Increasing numbers of biomanufacturing experts now believe that a completely disposable bioprocess stream is feasible and even within reach, according to the March 1 issue of GEN (www.genengnews.com/articles/chitem.aspx?aid=2818).